SYNAGILE
SynAgile™ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, continuous dopaminergic stimulation.
SYNAGILE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
Piedmont, California, United States
Country:
United States
Website Url:
http://www.synagile.com
Total Employee:
1+
Status:
Active
Contact:
510-908-3496
Email Addresses:
[email protected]
Total Funding:
11.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator OpenResty GoDaddy SSL
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Employees Featured
Founder
Official Site Inspections
http://www.synagile.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "SynAgile"
SynAgile - Crunchbase Company Profile & Funding
SynAgile™ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our …See details»
SynAgile 2025 Company Profile: Valuation, Funding
SynAgile General Information Description. Developer of a non-invasive drug delivery system designed to perform continuous delivery of levodopa and …See details»
Synagile Company Profile - Office Locations, Competitors ... - Craft
Synagile is a company developing DopaFuse, non-invasive therapy for the continuous delivery of levodopa and carbidopa. It is designed for Parkinson's disease patients and provides more …See details»
Press Release Distribution and Management - GlobeNewswire
WILSON, Wyoming, Sept. 22, 2021 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com), a privately held pharmaceutical company that develops and …See details»
SynAgile - The Org
SynAgile is a medical devices company developing DopaFuse®, the first patient-friendly, non-invasive therapy for continuous delivery of levodopa and carbidopa. Industries. Medical …See details»
SynAgile - Overview, News & Similar companies | ZoomInfo.com
Oct 26, 2021 SynAgile Corporation Announces Positive Phase 2 Top Line Results for DopaFuse® Levodopa-Carbidopa Delivery System SAN JOSE, Calif., Nov. 04, 2022 (GLOBE …See details»
Synagile Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Synagile Corporation of Wilson, WY. Get the latest business insights from Dun & Bradstreet.See details»
SynAgile - Company Profile - Tracxn
Feb 26, 2025 SynAgile is focused on developing and commercializing transformative therapeutics for Parkinson's disease. Uses its proprietary OraFuse intraoral continuous dosing …See details»
SynAgile Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore SynAgile Corp. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, and 1 literature.See details»
Synagile
SynagileSee details»
SynAgile Corporation Announces Positive Phase 2 Top Line Results …
SAN JOSE, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com) today announced positive results from its Phase 2 clinical trial of …See details»
SynAgile - Contacts, Employees, Board Members, Advisors & Alumni
SynAgile offers DopaFuse, an infusion therapy to stabilize L-DOPA levels in the body for patients who suffer from Parkinson’s disease. ... Log In. Log In. Experience the new Crunchbase, …See details»
SynAgile - Leadership Team - The Org
The Leadership Team at SynAgile is responsible for setting the strategic direction and vision for the company, guiding the development of innovative medical solutions like DopaFuse®. They …See details»
SynAgile Corporation Announces Positive Phase 2 Top Line
Nov 4, 2022 SynAgile is a privately-held startup company developing the OraFuse drug delivery platform for the administration of drugs where continuous oral delivery could be advantageous.See details»
SynAgile Corporation Announces Closing of Financing, …
Sep 22, 2021 SynAgile is a pharmaceutical company focused on developing and commercializing therapeutics using its proprietary OraFuse ® noninvasive, continuous, oral …See details»
SynAgile - Crunchbase
SynAgile offers DopaFuse, an infusion therapy to stabilize L-DOPA levels in the body for patients who suffer from Parkinson’s disease. Search Crunchbase. Start Free Trial . Chrome …See details»
SynAgile - Funding, Financials, Valuation & Investors - Crunchbase
Organization. SynAgile . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 2. obfuscated. Total Funding …See details»
SynAgile takes on debt to wrap up midphase trial of drug delivery ...
Sep 28, 2021 SynAgile began a phase 2 clinical trial of the device, OraFuse, earlier this year. ... Olanow is CEO of Clintrex, a clinical research organization collaborating with SynAgile on the …See details»
SynAgile Completes Enrollment of its Phase 2 Clinical Trial of its ...
Sep 1, 2022 SynAgile is a pharmaceutical company focused on developing and commercializing therapeutics using its proprietary OraFuse® noninvasive, continuous, oral dosing technology, …See details»
Agile Organizational Structure: Definition, Benefits & Examples
Dec 17, 2024 An agile organizational structure is a modern model that makes companies more flexible, efficient, and adaptable. The structures are characterized by flat hierarchies, agile …See details»